In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri
Open Access
Abstract
Free-living amoeba Naegleria fowleri causes a rapidly fatal infection primary amebic meningoencephalitis (PAM) in children. The drug of choice in treating PAM is amphotericin B, but very few patients treated with amphotericin B have survived PAM. Therefore, development of efficient drugs is a critical unmet need. We identified that the FDA-approved pitavastatin, an inhibitor of HMG Co-A reductase involved in the mevalonate pathway, was equipotent to amphotericin B against N. fowleri trophozoites. The genome of N. fowleri contains a gene encoding protein farnesyltransferase (FT), the last common enzyme for products derived from the mevalonate pathway. Here, we show that a clinically advanced FT inhibitor lonafarnib is active against different strains of N. fowleri with EC50 ranging from 1.5 to 9.2 µM. A combination of lonafarnib and pitavastatin at different ratios led to 95% growth inhibition of trophozoites and the combination achieved a dose reduction of about 2- to 28-fold for lonafarnib and 5- to 30-fold for pitavastatin. No trophozoite with normal morphology was found when trophozoites were treated for 48 h with a combination of 1.7 µM each of lonafarnib and pitavastatin. Combination of lonafarnib and pitavastatin may contribute to the development of a new drug regimen for the treatment of PAM.Keywords
Funding Information
- National Institutes of Health (1KL2TR001444, 1R21AI146460)
This publication has 31 references indexed in Scilit:
- Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States1Emerging Infectious Diseases, 2018
- Biology and pathogenesis of Naegleria fowleriActa Tropica, 2016
- Primary Amebic Meningoencephalitis: What Have We Learned in the Last 5 Years?Current Infectious Disease Reports, 2016
- Diagnosis, Clinical Course, and Treatment of Primary Amoebic Meningoencephalitis in the United States, 1937-2013Journal of the Pediatric Infectious Diseases Society, 2014
- Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleriInfection, Genetics and Evolution, 2011
- Pathogenic and opportunistic free-living amoebae:Acanthamoebaspp.,Balamuthia mandrillaris,Naegleria fowleri, andSappinia diploideaFEMS Immunology & Medical Microbiology, 2007
- FatalNaegleria fowleriMeningoencephalitis, ItalyEmerging Infectious Diseases, 2004
- Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animalsInternational Journal for Parasitology, 2004
- Primary amoebic meningoencephalitis with Naegleria fowleri: Clinical reviewPediatric Neurology, 1996
- Description of a Naegleria sp. isolated from two cases of primary amoebic meningo‐encephalitis, and of the experimental pathological changes induced by itThe Journal of Pathology, 1970